Farmacêutico de farmácia comunitária pergunta: entre desogestrel e drospirenona, qual apresenta menor atividade androgênica? Qual deles está associado a maior risco de eventos tromboembólicos?

Cebrim CFF

Palavras-chave


desogestrel, drospirenona, progestógenos, anticoncepcionais, tromboembolia, efeito androgênio.

Texto completo:

PDF

Referências


British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary. 65 ed. London: BMJ Publishing Group, APS Publishing, 2013. p. 513.

Truven Health Analytics: Drugdex® System. Thomson MICROMEDEX, Greenwood Village, Colorado, USA. [citado em: 06 Fev 2015]. Disponível em: http://www.micromedexsolutions.com.

Truven Health Analytics: Martindale: The Complete Drug Reference. Thomson MICROMEDEX, Greenwood Village, Colorado, USA. [citado em: 06 Fev 2015]. Disponível em: http://www.micromedexsolutions.com.

Borgsdorf LR, Cada DJ, Convington RT, Generali JA. Drug Facts and Comparisions. 60th edition. Saint Louis: Facts and Comparisons, 2006. p. 282.

Brunton LL, Lazo JS, Parker KL. (Ed.). Goodman & Gilman: As bases farmacológicas da terapêutica. 11. ed. Rio de Janeiro: McGraw-Hill Interamericana do

Brasil, 2007, p. 1415.

de Bastos Marcos, Stegeman Bernardine H., Rosendaal Frits R., Van Hylckama Vlieg Astrid, Helmerhorst Frans M, Stijnen Theo, Dekkers Olaf M. Combined oral contraceptives: venous thrombosis. Cochrane Database of Systematic Reviews. In: The

Cochrane Library, Issue 12, Art. No. CD010813. DOI: 10.1002/14651858.CD010813.pub3

Stegeman BH, de Bastos M, Rosendaal FR, Vlieg AH, Helmerhorst FM, Stijnen T, Dekkers OM. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ 2013; 347: f5298 doi:

1136/bmj.f5298 (Published 12 September 2013)

Lidegaard Ø, Nielsen LH, Skovlund CW, Skjeldestad FE, Løkkegaard E. Risk of venous thromboembolismuse of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ [Internet]. 2011 [citado 13 de janeiro de 2015];343. Disponível em: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202015/

Wu CQ, Grandi SM, Filion KB, Abenhaim HA, Joseph L, Eisenberg MJ. Drospirenone-containing oral contraceptive pills and the risk of venous and arterial

thrombosis: a systematic review. BJOG. 2013 Jun; 120(7): 801-10.

Dinger JC, Heinemann LA, Kühl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance

Study on oral contraceptives based on 142,475 women-years of observation. Contraception. 2007 May; 75(5):344-54.


Apontamentos

  • Não há apontamentos.


Direitos autorais 2015 Boletim Farmacoterapêutica



Boletim Farmacoterapêutica

ISSN - 2763-7654 (Versão eletrônica)

ISSN - 1413-9626 (Versão impressa)

Indexadores:

 

 

 

Logo logo Diadorim LATINDEX